1. Home
  2. VRA vs BTAI Comparison

VRA vs BTAI Comparison

Compare VRA & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.61

Market Cap

72.7M

ML Signal

HOLD

Logo BioXcel Therapeutics Inc.

BTAI

BioXcel Therapeutics Inc.

HOLD

Current Price

$1.64

Market Cap

36.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
BTAI
Founded
1982
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
36.5M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
VRA
BTAI
Price
$2.61
$1.64
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$26.67
AVG Volume (30 Days)
158.1K
301.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$416,097,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.61
$261.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$1.17
52 Week High
$3.41
$8.08

Technical Indicators

Market Signals
Indicator
VRA
BTAI
Relative Strength Index (RSI) 46.78 49.74
Support Level $1.89 $1.50
Resistance Level $2.84 $1.72
Average True Range (ATR) 0.16 0.11
MACD -0.01 0.02
Stochastic Oscillator 34.04 49.06

Price Performance

Historical Comparison
VRA
BTAI

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: